Phagestack

Germany · Biotech

A phage-discovery and development company that uses bacteriophage libraries, bioinformatics and machine learning to identify targeted solutions against bacterial strains.

Matching phages to bacterial targets

PhageStack combines a bacteriophage collection with computational analysis to find phages that act against a customer’s target bacteria. Its service analyzes bacterial genetics and bacteria–phage interactions to select candidate phages for development. The company describes applications across medical, agricultural, industrial and environmental settings; its core capability is enabling phage-based alternatives for problems involving bacteria, including antimicrobial resistance.

PhageStack serves organizations developing phage-based solutions. A customer supplies or identifies a bacterial target; the company uses its phage bank and bioinformatics to identify suitable candidates and support downstream solution development. Founded in 2023, it is an early-stage biotech company based in Pulheim, Germany.

Funding history

1 round · 0 with disclosed amounts
AnnouncedRoundAmountInvestors
NRW.BANK investmentUndisclosedNRW.BANK — Participant
Sourcesphagestack.com ↗nrwbank.de ↗